American Society for Parenteral and Enteral Nutrition

Global Enteral Feeding Formulas Market Report 2022: Ease of Use and Low Costs Driving Adoption - ResearchAndMarkets.com

Retrieved on: 
Monday, November 7, 2022
Managed Care, Diabetes, Health, General Health, Pharmaceutical, Food, Beverage, Oncology, Neurology, Retail, Hospitals, Fitness & Nutrition, Administration, Gastrointestinal tract, Parenteral nutrition, Intensive care unit, Growth, Nutrient, Society, Feeding tube, CAGR, American Society for Parenteral and Enteral Nutrition, Oncology, Route of administration, ASPEN, Stroke, Rehabilitation, Food, Nursing, GI, Degenerative disease, Malnutrition, Patient, Cancer, Abbott Laboratories, Hospital, Medicine, Milk, Diabetes

The Global Enteral Feeding Formulas Market size is expected to reach $8.6 billion by 2028, rising at a market growth of 8.5% CAGR during the forecast period.

Key Points: 
  • The Global Enteral Feeding Formulas Market size is expected to reach $8.6 billion by 2028, rising at a market growth of 8.5% CAGR during the forecast period.
  • This market is also expanding as many nursing homes and home healthcare organizations prefer enteral feeding formulas for rehabilitation of post-surgery patients.
  • as more neonatal care units develop, the market for enteral feeding formulas market will experience further growth.
  • These misunderstandings of the proper use of enteral feeding is expected to negatively impact the growth of the enteral feeding formula market.

Medscape Education to Host Nine Gastroenterology Symposia at Digestive Disease Week

Retrieved on: 
Thursday, May 19, 2022
Congress, American Society for Gastrointestinal Endoscopy, Medscape, Physician, Education, American Gastroenterological Association, Clostridioides difficile (bacteria), Irritable bowel syndrome, ASPEN, Rome, American College, Helicobacter pylori, American Association for the Study of Liver Diseases, DDW, Ulcerative colitis, AASLD, AGA, Crohn's & Colitis Foundation, Multimedia, Infection, International Foundation, View, Crohn's disease, Nursing, Route of administration, Institute of Liver and Biliary Sciences, CE, Society, CME, Association, Cleveland Clinic, American Society for Parenteral and Enteral Nutrition, Rehabilitation, Weill Cornell Medical College in Qatar, Gastroenterology, Feeding tube, American College of Gastroenterology, ACG, ASGE, Group, American Association, Degenerative disease, ROME, Gastrointestinal Endoscopy, Medicine, Online shopping

NEW YORK, May 19, 2022 /PRNewswire/ -- Medscape Education will host nine educational symposia at Digestive Disease Week (DDW) 2022 in San Diego May 21- 24, estimated to reach 3,000 gastroenterology specialists attending the conference in person.

Key Points: 
  • NEW YORK, May 19, 2022 /PRNewswire/ -- Medscape Education will host nine educational symposia at Digestive Disease Week (DDW) 2022 in San Diego May 21- 24, estimated to reach 3,000 gastroenterology specialists attending the conference in person.
  • The live symposia will address key topics in gastroenterology including inflammatory conditions and infectious diseases, such as ulcerative colitis, Helicobacter pylori infection, hepatobiliary carcinoma, Crohn's disease, Clostridioides difficile, irritable bowel syndrome, and more.
  • More than 30 expert clinicians from diverse education and practice environments, including Cleveland Clinic and Weill Cornell Medical will participate as presenting faculty.
  • Medscape's staff of gastroenterology experts, working with world-renowned faculty, are poised to engage clinicians through interesting, relevant, and interactive sessions," said Douglas Kaufman, Group Vice President of Medscape Education.

VectivBio Presents New Clinical Data Supporting Apraglutide for Treatment of Short Bowel Syndrome with Intestinal Failure (SBS-IF) Patients Who Have Renal Dysfunction at the 2022 American Society of Parenteral and Enteral Nutrition Conference

Retrieved on: 
Tuesday, March 29, 2022
Kidney, Urine, Company, Risk, Pantetheine, Drug development, Propionic acidemia, CIC, SBS, Chronic kidney disease, Nutrient, Coenzyme A, Form, ASPEN, PS, Organic acid, Forward-looking statement, Compliance, Manufacturing execution system, Nutrition, Route of administration, Conference, Patient, Failure, U.S. Securities and Exchange Commission, Short bowel syndrome, American Society for Parenteral and Enteral Nutrition, Poster, Quality of life, Respiration (physiology), Dehydration, Safety, STARS, Society, Nasdaq, COVID-19, Congenital disorders of amino acid metabolism, GLOBE, MMA, Phrase, Degenerative disease, Community of Metros, FDA, Disease, Security (finance), Pharmaceutical industry

BASEL, Switzerland, March 29, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today presented new clinical data demonstrating the potential of apraglutide, a next-generation, long-acting GLP-2 analog, as a novel treatment for short bowel syndrome with intestinal failure (SBS-IF) patients who have impaired renal function. The data were presented as a poster at the 2022 American Society for Parenteral and Enteral Nutrition Conference (ASPEN), taking place in Seattle, Washington and virtually on March 26-29, 2022.

Key Points: 
  • The data were presented as a poster at the 2022 American Society for Parenteral and Enteral Nutrition Conference (ASPEN), taking place in Seattle, Washington and virtually on March 26-29, 2022.
  • However, currently available GLP-2 therapy requires dose reduction and may not be suitable for these patients with moderate and severe renal impairment and end-stage renal disease.
  • As a next-generation GLP-2 analog peptide, apraglutide is metabolized into small peptides and amino acids via catabolic pathways, similar to endogenous GLP-2.
  • Importantly, these results are also clinically significant, as they show that apraglutide does not require dose adjustment for SBS-IF patients with and without renal impairment.

American Regent announces the launch of Selenious Acid Injection, USP in a 12 mcg/2 mL single-dose vial.

Retrieved on: 
Thursday, March 31, 2022
American Society for Parenteral and Enteral Nutrition, Parenteral nutrition, Risk, Selenium, Safety, Laboratory, Blood, Adult, AdeS, Pregnancy, Liver, Aluminium, Pharmacy, Route of administration, Miscarriage, Administration, Solution, Organic acid, Use, Feeding tube, Intake, Society, Lactation, Milk, Infant, Thrombosis, FDA, Birth, Calcium, Patient, Embolism, Dentistry, Vaccine, Birth control, Dietary supplement, PN

MELVILLE, N.Y., March 31, 2022 /PRNewswire/ -- American Regent, Inc. is pleased to announce the launch of Selenious Acid Injection, USP in a new concentration and vial size. The Selenious Acid family now includes a 12 mcg/2 mL (6 mcg/mL of selenium) single-dose vial designed for pediatric and neonatal patients less than 7 kg. Selenious Acid Injection is a trace element indicated in adult and pediatric patients as a source of selenium for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.¹ 

Key Points: 
  • Pulmonary Embolism due to Pulmonary Vascular Precipitates:If signs of pulmonary distress occur, stop the infusion and initiate a medical evaluation.
  • Vein Damage and Thrombosis: Selenious Acid Injection has a low pH and must be prepared and used as an admixture in PN solutions.
  • Pregnancy: Risk Summary:Administration of the recommended dose of Selenious Acid Injection in PN is not expected to cause major birth defects, miscarriage, or adverse maternal or fetal outcomes.
  • You are encouraged to report adverse drug events (ADEs) to American Regent:
    ADEs may also be reported to the FDA:

The Only Plant-Based, Organic Nutrition Shake Made to Help Meet the Specialized Nutrition Needs of People on Dialysis Is Now Available Thanks to Kate Farms

Retrieved on: 
Wednesday, February 16, 2022
Long-term care, Kate, Medicare, Potassium, Zinc, Patient, American Society for Parenteral and Enteral Nutrition, Cancer, CEO, WIC, Parent, Amazon (company), National Organic Program, Dialysis, Renal Support Network, Adult, U.S. Department of Defense Strategy for Operating in Cyberspace, Mineral, Sodium, U.S. Department of Agriculture Cotton Annex, Carbohydrate, MD, Insurance, Farm, Hospital, Iron, Jesse Compher, Malnutrition, JPEN, Allergen, USDA, Chronic kidney disease, COVID-19, Route of administration, Vitamin, Medicaid, Digestion, Vitamin and mineral supplementation for dialysis patients, Food, Dietary supplement, Health insurance, Woman

Renal Support 1.8 isthe only plant-based, organic shake designed to help meet the specialized nutrition needs of people on dialysis.

Key Points: 
  • Renal Support 1.8 isthe only plant-based, organic shake designed to help meet the specialized nutrition needs of people on dialysis.
  • Users can enjoy this low glycemic index food after dialysis treatments and deliver meaningful nutrition to the body3.
  • "We heard from the dialysis community, including patients and their healthcare providers about the need for intensive nutrition due to regular treatment so we created a one-of-its-kind organic shake to help meet their specialized needs," said Cynthia Ambres, MD, Kate Farms' Chief Medical Officer.
  • Renal Support 1.8 nutrition shake is made from high quality, plant-based ingredients and, like all Kate Farms products, Renal Support 1.8 is certified USDA Organic and Non-GMO Project Verified.

Spotlight On Malnutrition Month 2021: Academy Of Nutrition And Dietetics Highlights Initiatives To Address A Condition That Affects Many Hospitalized Seniors

Retrieved on: 
Tuesday, September 7, 2021

The Academy and its Foundation are facilitating initiatives to alleviate malnutrition.

Key Points: 
  • The Academy and its Foundation are facilitating initiatives to alleviate malnutrition.
  • The Malnutrition Quality Improvement Initiative is a project of the Academy, Avalere Health and key stakeholders collaborating to provide guidance and expertise for clinical malnutrition.
  • The initiative aims to advance evidence-based, high-quality, patient-driven care for hospitalized older adults who are malnourished or at-risk for malnutrition.
  • Representing more than 112,000 credentialed nutrition and dietetics practitioners, the Academy of Nutrition and Dietetics is the world's largest organization of food and nutrition professionals.

American Regent Launches Multrys™ (trace elements injection 4*, USP)

Retrieved on: 
Thursday, September 2, 2021
Patient, Research, Food and Drug Administration, Hypersensitivity, Copper, Blood, Society, Laboratory, Full, Feeding tube, Selenium, Zinc, Parenteral nutrition, Organic acid, Lists of diseases, Liver, Neurotoxicity, Risk, Cirrhosis, Route of administration, MRI, Center for Drug Evaluation and Research, Zinc sulfate, American Society for Parenteral and Enteral Nutrition, Cholestasis, Kidney, Disulfiram-like drug, FDA, Maximal and minimal elements, Center, Embolism, Serum, Administration, Thrombosis, AdeS, Food, Toxicity, Liver function tests, Electric battery, Fertilizer, Dietary supplement

Multrys (trace elements injection 4*)[package insert].

Key Points: 
  • Multrys (trace elements injection 4*)[package insert].
  • It is recommended only for patients who require supplementation with all four of the individual trace elements (zinc, copper, manganese and selenium).
  • Multrys is not recommended for patients who may require a lower dosage of one or more of the individual trace elements.Avoid additional manganese supplementation with Multrys use.
  • You are encouraged to report Adverse Drug Events (ADEs) to American Regent:
    ADEs may also be reported to the FDA:

Global Clinical Nutrition Market Forecasts and Growth Opportunities - Global Market Forecast to Grow from $59.6 Billion in 2020 to $75.4 Billion by 2025, at a CAGR of 4.8% - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 19, 2021
Diabetes, Fitness & Nutrition, Health, Other Health, European Society for Clinical Nutrition and Metabolism, Clinical nutrition, Academic journals, Health, American Society for Parenteral and Enteral Nutrition

In therapeutic applications, the report covers oncology, gastroenterology, nephrology, neurology, diabetes, immunology, critical care and other diseases.

Key Points: 
  • In therapeutic applications, the report covers oncology, gastroenterology, nephrology, neurology, diabetes, immunology, critical care and other diseases.
  • The healthcare settings segment includes acute care hospitals, nursing homes, homecare settings and inpatient rehabilitation facilities.\nThis report also includes a detailed background of medical nutrition therapy: oral nutrition supplements (dietary supplements, functional and fortified foods and food intolerance products) and clinical nutrition routes, enteral and parenteral.
  • Market sizing was done for infant, enteral, parenteral, adult and elder nutrition.
  • A regional market analysis for clinical nutrition is also covered in this report.\nThe research uncovers many paradigm shifts in the studied market, in terms of regional competitive advantage, competitive landscape among key players and market dynamics.

Aspen Physician Network and HASA HIE Launching a Clinically Integrated Network

Retrieved on: 
Wednesday, January 27, 2021
American Society for Parenteral and Enteral Nutrition, Nutrition

SAN ANTONIO, Jan. 27, 2021 /PRNewswire-PRWeb/ -- HASA , the non-profit, community HIE for North, South and West Texas, and Aspen Physician Network , an independent specialty physician group in Dallas-Fort Worth, Texas, have announced that HASA will be the technology foundation for a new clinically integrated network (CIN), which will reduce costs, increase efficiencies, and improve the quality of care for Aspen Physician Network's patients.

Key Points: 
  • SAN ANTONIO, Jan. 27, 2021 /PRNewswire-PRWeb/ -- HASA , the non-profit, community HIE for North, South and West Texas, and Aspen Physician Network , an independent specialty physician group in Dallas-Fort Worth, Texas, have announced that HASA will be the technology foundation for a new clinically integrated network (CIN), which will reduce costs, increase efficiencies, and improve the quality of care for Aspen Physician Network's patients.
  • HASA will serve as the platform for the CIN by allowing multiple independent practices in the specialty Aspen Physician Network to have access to and share one patient record.
  • "Having a central patient record is critical for launching a CIN," said Danny Conaway, Executive Director of Aspen Physician Network.
  • Aspen Physician Network, PLLC ("Aspen") exists to create an integrated panel of independent specialty physician groups to promote an environment of cooperation among providers and delivering quality care to the community.

Fresenius Kabi and ASPEN partner for an expert interview series on omega-3 fatty acid containing parenteral nutrition

Retrieved on: 
Monday, November 23, 2020
Nutrition, Health, Branches of biology, Parenteral nutrition, American Society for Parenteral and Enteral Nutrition, Fresenius, European Society for Clinical Nutrition and Metabolism, Omega-3 fatty acid, Fatty acid, Lipid, Journal of Parenteral and Enteral Nutrition, Calea UK

To support continuous health care professional (HCP) education on omega-3 fatty acids in clinical nutrition, the American Society for Parenteral and Enteral Nutrition (ASPEN) has partnered with Fresenius Kabi to create the Omega-3 Fatty Acids Key Expert Interview Series, which includes five interviews addressing important aspects of omega-3 fatty acids impacting patient care.

Key Points: 
  • To support continuous health care professional (HCP) education on omega-3 fatty acids in clinical nutrition, the American Society for Parenteral and Enteral Nutrition (ASPEN) has partnered with Fresenius Kabi to create the Omega-3 Fatty Acids Key Expert Interview Series, which includes five interviews addressing important aspects of omega-3 fatty acids impacting patient care.
  • Clinicians can also watch previous ASPEN webinars on omega-3 fatty acids:
    Expert Consensus on Omega-3 Fatty Acids in Parenteral Nutrition: Focus on Critical Care and Major Surgery
    The digital interviews and past webinars are supported by global clinical nutrition leader, Fresenius Kabi.
  • The supplement of the 2020 Journal of Parenteral and Enteral Nutrition Lipids in Parenteral Nutrition: Translating Guidelines into Clinical Practice was also developed on the topic of omega-3 fatty acids with support from Fresenius Kabi.
  • Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition.